{
    "Trade/Device Name(s)": [
        "Contrex Plus Low Control Solution"
    ],
    "Submitter Information": "Apex BioTechnology Corp.",
    "510(k) Number": "k100747",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I (reserved)",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "March 11, 2010",
    "Summary Letter Received Date": "March 16, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Quality Control Material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "D-glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "GlucoSure STAR Blood Glucose Monitoring System",
        "GlucoTRACK Blood Glucose Monitoring System"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Control",
        "Quality control material"
    ],
    "Document Summary": "FDA 510(k) summary for Contrex Plus Low Control Solution as a quality control material for validating blood glucose monitoring systems",
    "Indications for Use Summary": "Validates the performance of GlucoSure STAR & GlucoTRACK Blood Glucose Monitoring Systems using a control solution with a known range of glucose to ensure proper user technique and device function",
    "fda_folder": "Clinical Chemistry"
}